Advertisement

Current Obstetrics and Gynecology Reports

, Volume 8, Issue 4, pp 145–151 | Cite as

Promoting Cardiovascular Health in Midlife Women

  • Annette Jakubisin KonickiEmail author
Current Approaches to Managing Menopause (I Alexander, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Current Approaches to Managing Menopause

Abstract

Purpose of Review

Cardiovascular disease (CVD) remains the number one cause of death in the USA. In women, coronary heart disease (CHD) accounts for 22% of deaths with an additional 6.2% of deaths secondary to stroke. The prevalence of CVD increases as women age; after the age of 75, the incidence will exceed that reported for men. The risk for CVD in women is systematically underestimated. Both healthcare providers and women need a better understanding of the mechanism and role of traditional CVD risk factors (CVDRF) in women, and the newer identified non-traditional CVDRF which are unique to women and the resulting CVD morbidity and mortality.

Recent Findings

Women with a CVD event often do not present the same as men. During middle-age and the transition to post-menopause, the complaints women experience often do not match the standard male-oriented CVD symptoms, and thus are often erroneously attributed to menopause. Unique sex-gene expression and function account for the biological variances in both CVDRF and CVD prevalence and presentation in women. There is a need for a more sex-specific approach to CVDRF assessment and targeted reduction in women.

Summary

There are major differences in the risk, development, and presentation of CVD in women. A wide-spread awareness is lacking in women and healthcare providers of the unique sex-specific differences in both CVDRF and CVD in women. The traditional CVD risk factor assessment tools and CVD risk calculators do not account for these differences and systematically underestimate CVD risk in women.

Keywords

Cardiovascular disease in women Sex-specific cardiovascular disease risk Sex-specific cardiovascular disease symptoms Cardiovascular disease risk factors Non-traditional cardiovascular risk factors 

Notes

Compliance with Ethical Standards

Conflict of Interest

Annette Jakubisin Konicki declares that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Heron M. Deaths: leading causes for 2016. Natl Vital Stat Rep. 2016;67(6).Google Scholar
  2. 2.
    Mozaffarian JD, Benjamin SE, Go KA, Arnett JD, Blaha RM, Cushman JM, et al. Executive summary: heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133(4):447–54.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    •• Maffei S, Guiducci L, Cugusi L, Cadeddu C, Deidda M, Gallina S, et al. Women-specific predictors of cardiovascular disease risk - new paradigms. Int J Cardiol. 2019;286:190–7 This article identifies the sex-specific risk factors for cardiovascular disease and explores the possible correlation with events during a woman’s obstetric and gynecological history. PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Mosca HL, Linfante JA, Benjamin NE, Berra WK, Hayes PS, Brian WL, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation. 2005;111(4):499–510.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Mosca AL, Hammond AG, Mochari-Greenberger A, Towfighi AA, Albert AM. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation. 2013;127(11):1254–63.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Smith R, Frazer K, Hyde A, O'Connor L, Davidson P. “Heart disease never entered my head”: women's understanding of coronary heart disease risk factors. J Clin Nurs. 2018;27(21–22):3953–67.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    • Garcia M, Mulvagh SL, Merz CNB, Buring JE, Manson JE. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118(8):1273–93 This article reviews both novel and unique aspects of the traditional and non-traditional risk factor in women for cardiovascular disease. Implications for screening, prevention, and treatment are also reviewed. PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    •• Cifkova R, Pitha J, Krajcoviechova A, Kralikova E. Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach. Int J Cardiol. 2019;286:214–9 This review analyzes sex-specific aspects of the traditional cardiovascular risk factors and the impact for cardiovascular disease in women. PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Sciomer S, Moscucci F, Maffei S, Gallina S, Mattioli A. Prevention of cardiovascular risk factors in women: the lifestyle paradox and stereotypes we need to defeat. Eur J Prev Cardiol. 2019;26(6):609–10.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Regitz-Zagrosek V. Sex and gender differences in health. Science & Society Series on Sex and Science. EMBO Rep. 2012;13(7):596.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    • Maas AHEM. Maintaining cardiovascular health: an approach specific to women. Maturitas. 2019;124:68–71 This article reviews the sex-specific risk variable that are involved with non-obstructive and other types of ischemic heart disease seen more often in women. PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Sciomer S, Moscucci FC, Dessalvi CC, Deidda M, Mercuro G. Gender differences in cardiology: is it time for new guidelines? J Cardiovasc Med. 2018;19(12):685–8.CrossRefGoogle Scholar
  13. 13.
    Lloyd-Jones M, Hong JY, Labarthe FD, Mozaffarian KD, Appel CL, Linda VHM, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Mcguire S. Scientific report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Departments of Agriculture and Health and Human Services, 2015. Adv Nutr. 2016;7(1):202.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep. 2000;894:i.Google Scholar
  16. 16.
    Piercy LK, Troiano PR. Physical activity guidelines for Americans from the US Department of Health and Human Services: cardiovascular benefits and recommendations. Circ Cardiovasc Qual Outcomes. 2018;11(11):e005263–e005263.15.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    World Health Organization. The world health report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.Google Scholar
  18. 18.
    Saydah S, Bullard KM, Cheng Y, Ali MK, Gregg EW, Geiss L, et al. Trends in cardiovascular disease risk factors by obesity level in adults in the United States, NHANES 1999-2010. Obesity. 2014;22(8):1888–95.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital signs: prevalence of key cardiovascular disease risk factors for million hearts 2022 - United States, 2011–2016. MMWR Morb Mortal Wkly Rep. 2018;67(35):983.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Yu E, Rimm E, Qi L, Rexrode K, Albert CM, Sun Q, et al. Diet, lifestyle, biomarkers, genetic factors, and risk of cardiovascular disease in the Nurses' Health Studies. Am J Public Health. 2016;106(9):1616–23.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Collins P, Webb CM, de Villiers TJ, Stevenson JC, Panay N, Baber RJ. Cardiovascular risk assessment in women - an update. Climacteric. 2016;19(4):329–36.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Gulati M. Improving the cardiovascular health of women in the nation: moving beyond the bikini boundaries. Circulation. 2017;135(6):495–8.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Merz AA, Cheng S. Sex differences in cardiovascular ageing. Heart. 2016;102(11):825–31.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Lobelo DF, Rohm Young A, Deborah SRR, Garber JM, Billinger ES, Duperly VJ, et al. Routine assessment and promotion of physical activity in healthcare settings: a scientific statement from the American Heart Association. Circulation. 2018;137(18):e495–522.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    National Center for Health Statistics. Survey Description, National Health Interview Survey, 2018. Hyattsville, Maryland. 2019.Google Scholar
  26. 26.
    Mendoza N, De Teresa C, Cano A, Godoy D, Hita-Contreras F, Lapotka M, et al. Benefits of physical exercise in postmenopausal women. Maturitas. 2016;93:83–8.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Mandrup CM, Egelund J, Nyberg M, Lundberg Slingsby MH, Andersen CB, Løgstrup S, et al. Effects of high-intensity training on cardiovascular risk factors in premenopausal and postmenopausal women. Obstet Gynecol. 2017;216(4):384.e1–384.e11.Google Scholar
  28. 28.
    Riesco SE, Tessier SS, Lacaille SM, Pérusse SF, Côté SM, Després SJ-P, et al. Impact of a moderate-intensity walking program on cardiometabolic risk markers in overweight to obese women: is there any influence of menopause? Menopause. 2013;20(2):185–93.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Yeh M, Liao R, Hsu C, Chung Y, Lin J. Exercises improve body composition, cardiovascular risk factors and bone mineral density for menopausal women: a systematic review and meta-analysis of randomized controlled trials. Appl Nurs Res. 2018;40:90–8.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Grindler M, N., Santoro F, N Menopause and exercise. Menopause 2015;22(12):1351–1358.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Chomistek AK, Chiuve SE, Eliassen AH, Mukamal KJ, Willett WC, Rimm EB. Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J Am Coll Cardiol. 2015;65(1):43–51.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 2014;34(3):509–15.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Hayatbakhsh MR, Clavarino A, Williams GM, Sina M, Najman JM. Cigarette smoking and age of menopause: a large prospective study. Maturitas. 2012;72(4):346–52.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Yang L, Wang Z. Abstract 16460: differential impact of cigarette smoking on prognosis in women compared with men with coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2016;134:A16460.Google Scholar
  35. 35.
    Oertelt-Prigione S, Maas AH. Health inequalities in secondary prevention. Eur J Prev Cardiol. 2017;24(3):116–22.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Shivappa N, Hébert J, Kivimaki M, Akbaraly TN. Alternate healthy eating index 2010, dietary inflammatory index and risk of mortality: results from the Whitehall II cohort study and meta-analysis of previous dietary inflammatory index and mortality studies. Br J Nutr. 2017;118(3):210–21.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Halland H, Lønnebakken MT, Pristaj N, Saeed S, Midtbø H, Einarsen E, et al. Sex differences in subclinical cardiac disease in overweight and obesity (the FATCOR study). Nutr Metab Cardiovasc Dis. 2018;28(10):1054–60.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Nazare J, Smith J, Borel A, Aschner P, Barter P, Van Gaal L, et al. Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). Am J Cardiol. 2015;115(3):307–15.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans. 8th Edition. December 2015. Available at https://health.gov/dietaryguidelines/2015/guidelines/. Accessed 24 June 2019.
  40. 40.
    Mostofsky E, Mukamal KJ, Giovannucci EL, Stampfer MJ, Rimm EB. Key findings on alcohol consumption and a variety of health outcomes from the Nurses' Health Study. Am J Public Health. 2016;106(9):1586.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Lobo RA, Davis SR, De Villiers TJ, Gompel A, Henderson VW, Hodis HN, et al. Prevention of diseases after menopause. Climacteric. 2014;17(5):540–56.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Stachowiak G, Pertyński T, Pertyńska-Marczewska M. Metabolic disorders in menopause. Menopause Review. 2015;14(1):59–64.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Khoudary EI, Samar R. HDL and the menopause. Curr Opin Lipidol. 2017;28(4):328–36.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Peters AES, Muntner AEP, Woodward AEM. Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016. Circulation. 2019;139(8):1025–35.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D. Hypertension prevalence and control among adults: United States, 2015-2016. NCHS data brief 2017; no. 289.Google Scholar
  46. 46.
    Timpka S, Fraser A, Schyman T, Stuart J, Åsvold B, Mogren I, et al. The value of pregnancy complication history for 10-year cardiovascular disease risk prediction in middle-aged women. Eur J Epidemiol. 2018;33(10):1003–10.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Charlton F, Tooher J, Rye K, Hennessy A. Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ. 2014;23(3):203–12.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Savitz DA, Danilack VA, Elston B, Lipkind HS. Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery. Am J Epidemiol. 2014;180(1):41–4.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Smith GN, Pudwell J, Walker M, Wen S. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can. 2012;34(9):830–5.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127–248.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.Google Scholar
  52. 52.
    American Diabetes Association. 9. Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care 41:S86–S104.Google Scholar
  53. 53.
    Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol. 2002;89(12):12–7.CrossRefGoogle Scholar
  54. 54.
    Knowlton AA, Korzick DH. Estrogen and the female heart. Mol Cell Endocrinol. 2014;389(1–2):31–9.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Lagranha CJ, Silva TLA, Silva SCA, Braz GRF, Da Silva AI, Fernandes MP, et al. Protective effects of estrogen against cardiovascular disease mediated via oxidative stress in the brain. Life Sci. 2018;192:190–8.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Dworatzek E, Mahmoodzadeh S. Targeted basic research to highlight the role of estrogen and estrogen receptors in the cardiovascular system. Pharmacol Res. 2017;119:27–35.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Murphy E. Estrogen signaling and cardiovascular disease. Circ Res. 2011;109(6):687–96.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.School of NursingUniversity of ConnecticutMansfieldUSA

Personalised recommendations